Decreased Serum Levels of Soluble Oncostatin M Receptor (sOSMR) and Glycoprotein 130 (sgp130) in Patients with Coronary Artery Disease.

Autor:	Carvalho VMF; Universidade Federal de Pernambuco, Recife, PE - Brasil., Oliveira PSS; Universidade Federal de Pernambuco, Recife, PE - Brasil., Albuquerque APB; Universidade Federal de Pernambuco, Recife, PE - Brasil., Rêgo MJBM; Universidade Federal de Pernambuco, Recife, PE - Brasil., Rosa MMD; Universidade Federal de Pernambuco, Recife, PE - Brasil., Oliveira DC; Universidade Federal de Pernambuco, Recife, PE - Brasil., Pereira MC; Universidade Federal de Pernambuco, Recife, PE - Brasil., Pitta MGDR; Universidade Federal de Pernambuco, Recife, PE - Brasil.
Jazyk:	English; Portuguese
Zdroj:	Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2023 Mar; Vol. 120 (4), pp. e20220326.
DOI:	10.36660/abc.20220326
Abstrakt:	Background: Oncostatin M (OSM) is a pleiotropic cytokine which, after arterial injury, has proven to be to be rapidly expressed. Objectives: To correlate the serum levels of OSM, soluble OSM receptor (sOSMR), and soluble fraction of glycoprotein 130 (sgp130) in patients with coronary artery disease (CAD) with clinical parameters. Methods: Levels of sOSMR and sgp130 were evaluated by ELISA and OSM by Western Blot, in patients with CCS (n=100), patients with ACS (n=70), and 64 control volunteers without clinical manifestations of the disease. P-values < 0.05 were considered to be statistically significant. Results: CAD patients exhibited significantly lower levels of sOSMR and sgp130 and higher levels of OSM when compared to the controls (both p < 0.0001). Clinical analysis displayed, lower levels of sOSMR in men ([OR] = 2.05, p = 0.026), youth (OR = 1.68, p = 0.0272), hypertensives (OR = 2.19, p = 0.041), smokers (OR = 2.19, p = 0.017), patients that did not present dyslipidemia (OR = 2.32, p = 0.013), patients with Acute Myocardial Infarction [AMI] (OR = 3.01, p = 0.001) and patients not treated with statin (OR = 1.95, p = 0.031), antiplatelet agent (OR = 2.46, p = 0.005), inhibitors of calcium channels (OR = 3.15, p = 0.028), and antidiabetic drugs (OR = 2.97, p = 0.005). The levels of sOSMR were also correlated with gender, age, hypertension, and use of medications in multivariate analysis. Conclusions: Our data suggest that the enhanced serum levels of OSM, and decreased levels of sOSMR and sGP130 in patients with cardiac injury may play an important role in the pathophysiological mechanism of the disease. Furthermore, lower levels of sOSMR were associated with gender, age, hypertension, and the use of medications.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu